Risk factors

Summit Midstream faces heavy risks from debt service obligations of $1.0 billion, reliance on key customers, commodity price exposure, and environmental regulations.

SoundHound's risk profile is dominated by intense competition in the Voice AI market, execution risks from recent acquisitions like SYNQ3 and Amelia, and a history of substantial net losses and negative cash flows.

Stagwell faces concentration risk with CEO Mark Penn controlling 58 percent of voting power and Stagwell Media owning 57 percent of stock. Operations rely heavily on maintaining profitable client demand, protecting client data, and successfully integrating new investments like the Stagwell Marketing Cloud and AI. Complex corporate structures including the Up-C arrangement and Tax Receivables Agreement limit cash flow and impose significant tax and financial obligations.

Syra Health faces heavy customer concentration with FSSA providing 61 percent of 2024 revenue. The auditor issued a going concern warning with cash at $2.39 million. Insiders control 30.9 percent of voting securities through dual-class shares.

Tvardi Therapeutics is pursuing a reverse merger with Cara Therapeutics, involving significant ownership dilution and closing conditions.

International manufacturing footprint in China, Mexico, Brazil, and Vietnam exposes operations to foreign labor, trade policies, and currency volatility. Heavy reliance on major video service provider customers and third-party component suppliers creates revenue and supply chain concentration risks. Intellectual property protection and rapid technological changes in remote controls and smart home devices dictate competitive positioning.

This is an initial filing for Wheels Up Experience Inc., detailing 40 core risk factors.

Vroom emerged from Chapter 11 bankruptcy on January 14, 2025, altering its capital structure and eliminating long-term debt at the parent level.

Voyager Therapeutics faces substantial early-stage biotechnology risks, including no product revenues, heavy reliance on capital raises, and complex gene therapy manufacturing.

WBTN's risk profile is dominated by reliance on creators for content and NAVER for corporate and operational support. International expansion introduces severe regulatory compliance risks, particularly regarding data privacy, cybersecurity, and child safety. Currency fluctuations in the Korean won and Japanese yen significantly impact financial results.

WLFC relies heavily on debt financing and credit facilities that encumber substantially all of its assets. The company operates in a capital-intensive global market facing intense competition and regulatory scrutiny.

Exagen relies heavily on its flagship AVISE CTD test, running net losses and carrying an accumulated deficit of $294.3 million.